Received Jun 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Within a month of receiving the vaccine patient got shingles and terrible pain; This serious case was reported by a other health professional via sales rep and described the occurrence of shingles in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. In NOV-2024, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced shingles (Verbatim: Within a month of receiving the vaccine patient got shingles and terrible pain) (serious criteria other: Serious as per reporter). The outcome of the shingles was resolving. The reporter considered the shingles to be related to Shingrix. The company considered the shingles to be unrelated to Shingrix. Additional Information: GSK receipt date: 29-MAY-2026 The patient had gotten the Shingles vaccine and within a month got shingles and has had terrible pain for the last 18 months. The reporter reported just a day or two days ago did not have any more pain. The nurse did not know anymore and felt like it was probably reported already but needed to report again. The vaccination date was an estimated date because the nurse kept saying it was 18 months to two years that the doctor's wife (patient) has been dealing with this situation. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Herpes zoster, less than a month after receiving 1st dose of Shingrix in an elderly female patient. Case lacks further information on medical history, concurrent conditions and laboratory confirmation. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.